Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NBTY

This article was originally published in The Tan Sheet

Executive Summary

Vitamin/supplement maker and several execs named defendants in a shareholder class action suit filed July 28 in Uniondale, N.Y. federal court on behalf of purchasers of NBTY stock between Jan. 27 and June 15. The lawsuit alleges the defendants, during the period in question, failed to disclose several adverse factors, including declining Vitamin World same-store sales due to a negative industry-wide trend and a negative impact on financial results from U.K. operations caused by fluctuation in the British pound sterling. The lawsuit alleges NBTY's stock dropped 36% following a June 15 company announcement regarding same-store sales and foreign currency weaknesses (1"The Tan Sheet" July 17, p. 10)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091547

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel